Technology and products

Article Abstract:

Denver, CO-based Ischemia Technologies filed a 510(k) pre-market notification with the FDA for clearance to market its Albumin Cobalt Binding (ACB) test. The test lets emergency personal know if a patient can be ruled out for heart attack.

Colorado, Cardiovascular Preparations, Cardiovascular agents, Ischemia Technologies Inc.

---

Genset/Sonofi: CNS drug discovery

Article Abstract:

Paris, France-based Genset has signed an agreement with New York, NY-based Sanofi-Synthelabo to initiate a pharmacogenomics collaboration focused on lead selection and optimization for an undisclosed CNS disease.

Central Nervous System Prep, Brief Article, Central nervous system agents, Sanofi-Synthelabo, Genset S.A.

---

Medicine and applications

Article Abstract:

The introduction of clot-busting drugs has dramatically the death rates from stroke and acute myocardial infarction (AMI).

Anticoagulant Preparations, Anticoagulants

Similar abstracts:

• Abstracts: Medicine and applications: biochips. Medicine and applications. PE Biosystems: automated system for genotyping of mutations in HIV
• Abstracts: Identifying new patient prospects: efficacy of usage segmentation. Complaint intensity and health care services: a framework to establish priorities for quality improvements can be used to improve patient satisfaction
• Abstracts: Physician opportunity costs in physician practice cost functions. A problem with consumer surplus measures of the cost of practice variations
• Abstracts: CPRTraining. Theory and reality. The health care 100
• Abstracts: The pills that ate your profits. Look before you launch. Medicaid: states serve up a real turkey

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.